Why the study?
Does almokalant alter electrophysiologic refractoriness in a porcine model?
Does almokalant alter electrophysiologic refractoriness in a porcine model?
Almokalant prolongs refractoriness more in the atrium than the ventricle without reverse-use dependence in a porcine model, suggesting potential utility for treating supraventricular tachyarrhythmias.
No takes yet. Share an insight, caveat, or question.
May inform atrial-selective antiarrhythmic development; leaves open human translation from this porcine model.
Wiesfeld et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: